Redshift Bioanalytics, Inc. is a biotechnology company based in Burlington, MA, specializing in advanced analytical solutions for biopharmaceutical development. The organization focuses on the development of innovative technologies that enhance the characterization of biomolecules, particularly in the areas of protein analysis and formulation. By leveraging cutting-edge methodologies, Redshift aims to streamline the drug development process, ensuring that therapeutic candidates are thoroughly evaluated for efficacy and safety.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

14 Patents

#44 in Burlington, MA

#1,364 in Massachusetts

#22,333 in US

#42,290 in the World

Burlington, MA, United States of America

Redshift Bioanalytics, Inc.

Forward Citations = 45

12 inventors:

Charles McAlister Marshall (11 out of 33 patents)

Donald Kuehl (7 out of 10 patents)

Jeffrey Guasto (7 out of 8 patents)

4. Eugene Yi-Shan Ma (5 out of 6 patents)

5. Matthias Wagner (4 out of 49 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Redshift Bioanalytics, Inc.. Retrieved from https://idiyas.com/company/redshift-bioanalytics

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]